iconFeatured Content


Ovarian Cancer – Bradley Monk, MD, and Robert Figlin, MD, provide post ESMO ’19 clinical update


iconExpert Video Insights

iconOBR Green

View Archives

October 2019 Edition

At ESMO 2019, the biggest clinical news was three late-stage standout studies in first-line advanced ovarian cancer with the PARP inhibitors niraparib, olaparib, and veliparib. Data from...

October 2019 Edition

A round-up of some of the notable pivotal trial data presented in Barcelona that expanded treatment options for patients, including studies in triple negative breast cancer (KEYNOTE-522),...

October 2019 Edition

At Flatiron’s OncoCloud ’19 meeting, OBR sat down with three leading OneOncology providers to talk about how implementing data-connectivity through cloud-based oncology software like ...

October 2019 Edition

In another exclusive report, OnPoint Oncology provides an analysis of the largest non-Blue Commercial plans compared to the gold standard, Medicare. The analysis looks at the data on deni...


Third-Line Treatment in Metastatic Colorectal Cancer Po...

Oct 07, 2019

Targeted oral tyrosine kinase inhibitors (TKIs) have an established role in third-line treatment of metastatic colorectal cancer (mCRC), but an expert outlined an...

ESMO Opens with Survival Benefits from Long-Term Data i...

Sep 30, 2019

The 2019 European Society of Medical Oncology (ESMO) opened with a series of trials with positive overall survival (OS) data. Generally considered the gold standa...

Rapid Integration of Information Presented at 2019 ASCO...

Jul 15, 2019

Introduction OBR and MDoutlook are pleased to share excerpts from the most recent MDoutlook OncoPolls™ following this year’s ASCO annual meeting in ...

iconOBR Tools


Stemming from the user preference that you set, stay informed and increase your productivity via 27/7 web based access to Ontellitrac and a customized email alert system summarizing the most recent oncology-specific information available.

Learn More

The Oncology Business Dynamics Learning Platform addresses the need to have a high level of understanding of the non-clinical issues that are influencing the decision making process for hem/oncs today.

Learn More

Sponsored Content

Original articles, thought leader interviews, and other resources covering testing, patient selection and treatment options in AML

Supported by:

Learn More

We explore the scope of the escalating cost of cancer care, discuss the factors that contribute to the total cost of cancer care, and provide resources to help us all understand the facts regarding the cost of cancer care.

Sponsored by:

Learn More

Oncology Events Calendar

October 25 - 26, 2019
October 30 - November 1, 2019
November 14, 2019
December 3, 2019
December 4 - 6, 2019
December 7 - 10, 2019
December 10 - 14, 2019
January 22 – 24, 2020
February 6 - 8, 2020
March 4 – 6, 2020
March 21, 2020
April 24 - 29, 2020

AACR Annual Meeting 2020

San Diego, CA

May 29 - June 2, 2020